0.3552
5.53%
-0.0208
After Hours:
.35
-0.0052
-1.46%
Oragenics Inc Stock (OGEN) Forecast
The Oragenics Inc (OGEN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.5436, representing a +1,742% increase from the current price of $0.3552. The highest analyst price target is $9.5554, and the lowest is $3.5318.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OGEN Price Target
Average 52.03
(+14,548% Upside)
Is Oragenics Inc (OGEN) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 53.34 | Neutral |
STOCH(9,6) | 34.11 | Neutral |
STOCHRSI(14) | 49.11 | Neutral |
MACD(12,26) | 0.00469 | Buy |
ADX(14) | 18.34 | Neutral |
William %R | -63.09 | Neutral |
CCI(14) | 24.86 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
0.3476
Buy
|
0.3457
Buy
|
MA20 |
0.3325
Buy
|
0.3389
Buy
|
MA50 |
0.3265
Buy
|
0.3817
Sell
|
MA100 |
0.5618
Sell
|
0.5929
Sell
|
MA200 |
0.9807
Sell
|
1.2061
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, OGEN could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on OGEN, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 53.34 indicates that OGEN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.11 indicates that OGEN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 49.11 indicates that OGEN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.34 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.86 indicates that OGEN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term OGEN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oragenics Inc financial reports and earnings history, Oragenics Inc (OGEN) stock could reach $26.15 by 2030, $17.56 by 2040 and $43.11 by 2050. See the projected annual prices until 2050 of the Oragenics Inc stock below:
- Oragenics Inc (OGEN) is expected to reach an average price of $3.5828 in 2035, with a high prediction of $4.2876 and a low estimate of $3.7128. This indicates an $908.66% rise from the last recorded price of $0.3552.
- Oragenics Inc (OGEN) stock is projected to chart a bullish course in 2040, with an average price target of $17.47, representing an $4,818% surge from its current level. The forecast ranges from a conservative $17.43 to a sky-high $17.56.
- Our analysts predict Oragenics Inc (OGEN) to jump 7,082% by 2045, soaring from $24.68 to an average price of $25.51, potentially reaching $24.68. While $24.68 is the low estimate, the potential upside is significant.
- Oragenics Inc (OGEN) stock is expected to climb by 2050, reaching an average of $43.45, a $12,132% jump from its current level. However, a wide range of estimates exists, with high and low targets of $43.11 and $44.51, respectively, highlighting the market's uncertainty.
Oragenics Inc Stock (OGEN) Year by Year Forecast
Oragenics Inc Stock (OGEN) Price Forecast for 2025
Oragenics Inc Stock (OGEN) is expected to reach an average price of $52.03 in 2025, with a high prediction of $103.56 and a low estimate of $0.4955. This indicates an +14,548% rise from the last recorded price of $0.3552.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $4.3898 | $3.5318 | $9.5554 | +1,136% |
February, 2025 | $2.5542 | $0.7662 | $4.8849 | +619.09% |
March, 2025 | $19.43 | $1.9273 | $19.43 | +5,369% |
April, 2025 | $11.79 | $4.4179 | $28.76 | +3,218% |
May, 2025 | $0.1475 | $0.4955 | $28.24 | -58.47% |
June, 2025 | $9.2669 | $0.5216 | $20.30 | +2,509% |
July, 2025 | $8.5504 | $7.302 | $23.98 | +2,307% |
August, 2025 | $38.57 | $7.6955 | $57.17 | +10,760% |
September, 2025 | $41.95 | $29.67 | $103.56 | +11,709% |
October, 2025 | $13.46 | $11.21 | $43.93 | +3,690% |
November, 2025 | $13.69 | $10.99 | $27.59 | +3,753% |
December, 2025 | $7.9646 | $6.0746 | $26.12 | +2,142% |
Oragenics Inc Stock (OGEN) Price Forecast for 2026
The predicted value for Oragenics Inc (OGEN) in 2026 is set at an average of $45.89. Estimates vary from a peak of $89.14 to a trough of $2.643, indicating an +12,820% surge from the present price of $0.3552.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $4.917 | $2.643 | $13.61 | +1,284% |
February, 2026 | $6.4954 | $4.6832 | $19.20 | +1,729% |
March, 2026 | $36.49 | $5.1816 | $56.37 | +10,173% |
April, 2026 | $59.23 | $32.69 | $89.14 | +16,576% |
May, 2026 | $39.75 | $21.43 | $65.33 | +11,091% |
June, 2026 | $33.72 | $30.30 | $41.70 | +9,392% |
July, 2026 | $19.64 | $17.84 | $37.96 | +5,429% |
August, 2026 | $30.80 | $18.66 | $34.40 | +8,571% |
September, 2026 | $22.88 | $20.48 | $31.50 | +6,342% |
October, 2026 | $26.10 | $17.43 | $52.56 | +7,249% |
November, 2026 | $27.16 | $19.86 | $29.03 | +7,546% |
December, 2026 | $22.37 | $19.80 | $28.51 | +6,197% |
Oragenics Inc Stock (OGEN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oragenics Inc (OGEN) is $16.14, with a high forecast of $31.24 and a low forecast of $1.0405. This indicates an +4,445% increase from the last price of $0.3552.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $19.75 | $18.70 | $23.26 | +5,461% |
February, 2027 | $18.56 | $18.24 | $31.24 | +5,125% |
March, 2027 | $14.50 | $11.61 | $22.93 | +3,983% |
April, 2027 | $14.29 | $11.81 | $21.46 | +3,922% |
May, 2027 | $11.65 | $9.9667 | $16.16 | +3,179% |
June, 2027 | $6.7124 | $4.7262 | $12.94 | +1,790% |
July, 2027 | $7.9548 | $5.9055 | $11.08 | +2,140% |
August, 2027 | $8.9452 | $7.4299 | $12.67 | +2,418% |
September, 2027 | $7.9287 | $1.0405 | $9.9503 | +2,132% |
October, 2027 | $7.6951 | $4.4011 | $8.8498 | +2,066% |
November, 2027 | $10.23 | $5.3882 | $10.80 | +2,781% |
December, 2027 | $11.88 | $8.2537 | $13.33 | +3,245% |
Oragenics Inc Stock (OGEN) Price Forecast for 2028
In 2028, Oragenics Inc (OGEN) is projected to reach an average price of $6.9362, with a high projection of $13.43 and a low estimate of $0.4464. This indicates an +1,853% rise from the last price of $0.3552.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $6.6614 | $6.5054 | $13.43 | +1,775% |
February, 2028 | $3.6978 | $3.2838 | $9.3616 | +941.05% |
March, 2028 | $3.4433 | $2.4562 | $7.5709 | +869.40% |
April, 2028 | $2.6277 | $1.8657 | $4.5986 | +639.78% |
May, 2028 | $0.0812 | $0.5881 | $3.5488 | -77.14% |
June, 2028 | $0.0336 | $0.4464 | $1.3356 | -90.54% |
July, 2028 | $1.464 | $1.7254 | $1.2802 | +312.16% |
August, 2028 | $3.7986 | $2.1509 | $2.7175 | +969.42% |
September, 2028 | $3.7972 | $3.936 | $4.0423 | +969.03% |
October, 2028 | $4.0223 | $3.7299 | $3.7637 | +1,032% |
November, 2028 | $3.1432 | $3.4187 | $3.2913 | +784.91% |
December, 2028 | $2.5178 | $2.5958 | $2.913 | +608.84% |
Oragenics Inc Stock (OGEN) Price Forecast for 2029
The 2029 price forecast for Oragenics Inc Stock (OGEN) is $12.16 on average, with a high prediction of $24.31 and a low estimate of $0.0121. This represents an +3,324% increase from the previous price of $0.3552.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $1.4603 | $1.5451 | $2.2627 | +311.12% |
February, 2029 | $2.1779 | $1.7172 | $1.871 | +513.14% |
March, 2029 | $1.3355 | $1.4917 | $1.2948 | +275.98% |
April, 2029 | $0.7981 | $1.0831 | $1.2625 | +124.69% |
May, 2029 | $0.1776 | $0.1562 | $0.57 | -50.00% |
June, 2029 | $0.0548 | $0.0548 | $0.3948 | -84.57% |
July, 2029 | $2.5935 | $0.0121 | $2.9672 | +630.16% |
August, 2029 | $0.2673 | $0.3173 | $4.8003 | -24.75% |
September, 2029 | $1.0851 | $0.2811 | $1.712 | +205.49% |
October, 2029 | $0.2594 | $0.4225 | $1.2882 | -26.98% |
November, 2029 | $0.227 | $0.2563 | $0.1464 | -36.10% |
December, 2029 | $27.34 | $0.0677 | $24.31 | +7,596% |
Oragenics Inc Stock (OGEN) Price Forecast for 2030
Oragenics Inc Stock (OGEN) is expected to reach an average price of $19.18 in 2030, with a high forecast of $28.80 and a low forecast of $9.5606. This signifies an +5,299% surge from the last price of $0.3552.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $26.50 | $27.58 | $26.15 | +7,361% |
February, 2030 | $26.19 | $26.54 | $25.22 | +7,273% |
March, 2030 | $27.06 | $27.22 | $26.28 | +7,518% |
April, 2030 | $29.97 | $30.45 | $28.80 | +8,337% |
May, 2030 | $20.69 | $20.82 | $27.62 | +5,725% |
June, 2030 | $24.45 | $25.28 | $23.89 | +6,784% |
July, 2030 | $18.59 | $21.54 | $24.80 | +5,133% |
August, 2030 | $19.80 | $18.05 | $17.80 | +5,476% |
September, 2030 | $20.77 | $18.74 | $19.84 | +5,747% |
October, 2030 | $16.79 | $18.43 | $21.35 | +4,627% |
November, 2030 | $16.13 | $9.5606 | $10.60 | +4,441% |
December, 2030 | $14.72 | $14.22 | $13.39 | +4,044% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):